Stockreport

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children wi...

Insulet Corporation  (PODD) 
Last insulet corporation earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.insulet.com/investor-relations
PDF ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® b [Read more]